Jump Financial’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
NCNMGF
MBAM
Jump Financial's XGN Position: Q3 2026 in Review
Jump Financial increased its Exagen (XGN) stake by 597% in Q3 2026, buying an estimated $450K and bringing the position to 81,714 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Jump Financial first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.
- Jump Financial held 81,714 shares of Exagen worth $664K as of Q3 2026.
- Jump Financial bought 69,989 Exagen shares in Q3 2026, an estimated $450K.
- Exagen made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #1557 holding.
- Jump Financial first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
- 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.